Economic analysis of gene expression profile data to guide adjuvant treatment in women with early-stage breast cancer.
Cosler
Leon E
LE
Department of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, Albany, New York 12208-3492, USA.
Lyman
Gary H
GH
D000970:Antineoplastic Agents / Q000191:economics / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000235:genetics*; D001943:Breast Neoplasms / Q000235:genetics / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D017024:Chemotherapy, Adjuvant / Q000191:economics; D017046:Cost Savings; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D005260:Female; D020869:Gene Expression Profiling / Q000191:economics* / Q000379:methods; D015972:Gene Expression Regulation, Neoplastic; D017048:Health Care Costs; D006801:Humans; D018803:Models, Economic; D009010:Monte Carlo Method; D009367:Neoplasm Staging; D020411:Oligonucleotide Array Sequence Analysis / Q000191:economics*; D018579:Patient Selection; D010597:Pharmacogenetics / Q000191:economics* / Q000379:methods; D011237:Predictive Value of Tests; D019057:Quality-Adjusted Life Years; D011960:Receptors, Estrogen / Q000032:analysis; D015203:Reproducibility of Results; D018570:Risk Assessment; D013997:Time Factors; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D011960:Receptors, Estrogen